PASS-predicted Vitex negundo activity: antioxidant and antiproliferative properties on human hepatoma cells--an in vitro study.

Farkaad A Kadir
Farkaad A Kadir
University of Malaya
Dr  Normadiah M Kassim, MBBS, MSc, PhD
Dr Normadiah M Kassim, MBBS, MSc, PhD
University of Malaya
Professor Dr
Anatomy, Developmental Anatomy
Kuala Lumpur, Federal Territory | Malaysia
Mahmood A Abdulla
Mahmood A Abdulla
University of Malaya
Wageeh A Yehye
Wageeh A Yehye
University of Malaya

BMC Complement Altern Med 2013 Dec 4;13:343. Epub 2013 Dec 4.

Department of Anatomy, Faculty of Medicine, University of Malaya, 50603, Kuala Lumpur, Malaysia.

Background: Hepatocellular carcinoma is a common type of tumour worldwide with a high mortality rate and with low response to current cytotoxic and chemotherapeutic drugs. The prediction of activity spectra for the substances (PASS) software, which predicted that more than 300 pharmacological effects, biological and biochemical mechanisms based on the structural formula of the substance was efficiently used in this study to reveal new multitalented actions for Vitex negundo (VN) constituents.

Methods: Experimental studies based on antioxidant and antiproliferative assays verified the predictions obtained by the PASS-predicted design strategy. Antioxidant activity of VN extract was studied using 1,1-diphenyl-2-picrylhydrazyl (DPPH) and Ferric reducing or antioxidant power (FRAP) assays. The antiproliferative activity of VN extract against WRL68 and HepG2 was investigated based on methylthiazol tetrazolium (MTT) spectrophotometric assay.

Results: VN extract showed 79.43% inhibition of DPPH stable radical with IC50 13.31 ± 0.18 μg/ml. This inhibition was too closed to butylated hydroxyl toluene (BHT) 82.53% (IC5013.8 ± 0.14) and gallic acid 89.51% (IC50 3.1 ± 0.08). VN extract exhibited the strongest free radical scavenging power compared with two commercial antioxidants, BHT and ascorbic acid. VN increased the activities of antioxidant enzymes in normal embryonic liver cells (WRL68) including, superoxide dismutase (SOD) and glutathione peroxidase (GPX) compared with to H2O2 group. The ethanolic extract of VN showed cytotoxicity to HepG2 cells in a dose and time-dependent manner with IC50 66.46 μg/ml, 57.36 μg/ml and 65.12 μg/ml at 24, 48, and 72-hours incubation respectively, with no sensitivity in WRL68 cells. This was associated with significant elevation in lactate dehydrogenase (LDH) release in HepG2 cells. In addition, the activation of caspase-3 enzyme suggesting that the observed cytotoxicity was mediated via an intrinsic apoptosis pathway.

Conclusions: PASS-predicted plant activity could efficiently help in selecting a promising pharmaceutical leads with high accuracy and required antioxidant and antiproliferative properties. This is the first report on PASS-predicted VN activity.

Download full-text PDF

Source Listing

Still can't find the full text of the article?

We can help you send a request to the authors directly.
December 2013
49 Reads
5 Citations
2.020 Impact Factor

Publication Analysis

Top Keywords

antioxidant antiproliferative
antiproliferative properties
hepg2 cells
activity extract
vitex negundo
strongest free
exhibited strongest
free radical
radical scavenging
scavenging power
extract exhibited
ic50 008
014 gallic
ic50138 014
8253% ic50138
gallic acid
acid 8951%


(Supplied by CrossRef)

L W.Y Lau et al.
Article in Cancer letters
CS-F Cheung et al.
Cancer letters 2007
Article in Biomedicine & pharmacotherapy
L Ganju et al.
Biomedicine & pharmacotherapy 2003
Article in Journal of agricultural and food chemistry
S Ramos et al.
Journal of agricultural and food chemistry 2005
Article in Free Radic Biol Med
M Goodman et al.
Free Radic Biol Med 2011
Article in Fitoterapia
VR Tandon et al.
Fitoterapia 2008
Article in Scientific world
L Gautam et al.
Scientific world 2010
Article in Pharmacologyonline
P Singh et al.
Pharmacologyonline 2011
Article in Microsc Res Tech
R Manikandan et al.
Microsc Res Tech 2011
Article in Pharm Biol
C-J Zheng et al.
Pharm Biol 2010
Article in Arch Pharm Res
Y Avadhoot et al.
Arch Pharm Res 1991

Similar Publications